HIV-1 evolved into various genetic subtypes and circulating recombinant forms (CRFs) 3 2 in the global epidemic, with the same subtype or CRF usually having similar phenotype.
Geno2pheno FPR distribution among the plasma viral quasispecies in each participant 1 3 9 again found higher frequency of X4-using variants in people infected by CRF01_AE 1 4 0 cluster 4 than by cluster 5, CRF07_BC and subtype B (Fig. 2 and SI Appendix, Fig. S3 1 4 1 and Table S2 ). Together, deep sequencing on samples collected within the first year of To confirm the genetic prediction phenotypically, we isolated viruses using 1 4 4 cryopreserved PBMC from the deep sequenced CRF01_AE participants and conducted 1 4 5 coreceptor tropism assays using GHOST cell lines. A total of 24 viruses were 1 4 6 successfully isolated. Five showed X4-using phenotype and the remaining 19 were R5-1 4 7 only phenotype (Fig. 3A-C) . All of the five isolates with X4-using phenotype, including 1 4 8 1 7 0 Genetic and structural determinants for higher CXCR4 usage propensity 1 7 1
To explore the mechanism for higher X4-using propensity exhibited by cluster 4 viruses, 1 7 2 we first compared the V3 loop sequences between clusters 4 and 5. We found that 1 7 3 cluster 4 viruses have two highly conserved basic amino acids at positions 13 and 32 in 1 7 4 its V3 loop (R13 and K32, HXB2 numbering R308 and K327), which were present in 1 7 5 only about 8% of the cluster 5 viruses ( Fig. 4A-B ). These two conserved amino acids 1 7 6 confer cluster 4 viruses a higher positively charged V3 loop, upon which fewer 1 7 7 mutations may be required to switch from the R5 to X4 phenotype. Structure analysis 1 7 8 using V3-docking models (18) suggested that residue R13 in cluster 4 potentially forms 1 7 9 salt bridges with D262 and E277 and a hydrogen bond with the side chain of H281 in 1 8 0 the CXCR4 coreceptor, while the corresponding residue in cluster 5 may form hydrogen 1 8 1 bonds with K22 and D276 in the CCR5 coreceptor ( Fig. 4C ). Because the ligand binding 1 8 2 pocket of CXCR4 is more negatively charged than that in CCR5, the positively charged 1 8 3 residue R13 in cluster 4 viruses is more favored. The residue K32 in cluster 4 may form 1 8 4 salt bridges with CXCR4's N terminus, which contains more acidic residues than 1 8 5 CCR5's N terminus (Fig. 4C) . Therefore, the highly conserved residues R13 and K32 in 1 8 6 cluster 4 may be key determinants for the higher tendency of X4 usage. Interestingly, Despite the fact that R13 and K32 were present in vast majority of cluster 4 viruses, 1 0 but one X4-using sequences had residue K at this position (Fig. 6A ). Third, either E or D 2 1 4 were found at position 25 in R5 sequences, however, non-E/D substitutions (S/A/G) 2 1 5 were present in majority of X4-using sequences (Fig. 6A ). Interestingly, none of the X4 2 1 6 sequences have positively charged amino acid R or K at V3 position 11 or 25, which are 2 1 7 important for X4 usage in other HIV-1 subtypes (19) (20) (21) . This implies different 2 1 8 evolutionary pathway of coreceptor switching in CRF01_AE HIV-1. In genotypic 2 1 9 prediction, all X4-using sequences had Geno2pheno FPR values below 2%, and V3 net 2 2 0 charge no less than 5. In contrast, all R5 sequences had FPR values higher than 2%, 2 2 1 and V3 net charge no more than 5. As expected, cluster 4 has an overall higher V3 net 2 2 2 charge than cluster 5 ( Fig. 6A ). Notably, five sequences in cluster 4 with FPR below 5% 2 2 3 were in fact R5-only phenotype (Fig. 6A ). Therefore, using FPR 5% as the cutoff may 2 2 4 significantly overestimate the prevalence of X4 phenotype in CRF01_AE. Using the CCR5-V3 and CXCR4-V3 complex models (22, 23) , we also investigated the 2 2 7 role of V3 positions 7, 8 and 25 in viral tropism from a structural perspective. In the 2 2 8 model of CCR5-V3 complex, residue T8 in R5 V3 loop is surrounded by hydrophilic 2 2 9 amino acids, suggesting that residue T8 is more favored by hydrophilic environment. However, in the model of CXCR4-V3 complex, residue I8 in the X4 V3 loop is 2 3 1 surrounded by hydrophobic amino acids (Fig. 6B ). This could explain why all X4 viruses 2 3 2 have T to I/M substitutions at position 8 because the residue T8 may not well fit the 2 3 3 hydrophobic environment within CXCR4's ligand binding pocket. In the CXCR4-V3 2 3 4 complex, V3 position 7 is surrounded by negatively charged residues, which favor the 2 3 5 interaction with positively charged residues K7 in X4 sequences (Fig. 6B ). Compared to 2 3 6 1 1 the corresponding region in the ligand binding pocket of CXCR4, the ligand binding 2 3 7 pocket in CCR5 around V3 position 25 contains more positively charged residues, 2 3 8 which are favored for interacting with the negatively charged residues D/E25. This 2 3 9 explained why all R5 viruses have D/E at V3 position 25. However, D/E may be less 2 4 0 favored in the less positively charged environment in the ligand binding pocket of 2 4 1 CXCR4 ( Fig. 6B ). Therefore, non-D/E substitutions as observed in X4-using sequences 2 4 2 would be required for efficient X4 binding ( Fig. 6B ). Taken together, genetic analysis in 2 4 3 combination with structural modeling showed that specific V3 substitutions at position 7, 2 4 4 8 and 25 may be required to achieve X4-using phenotype in the context of CRF01_AE 2 4 5 cluster 4 envelope. Since the initial introduction to human in the early 20th century, HIV-1 evolved 2 4 9 genetically and biologically with faster pace than other viruses, due to both the high 2 5 0 error-prone nature of its reverse transcriptase and the unusual transmission routes, HIV-1 epidemic with multiple subtypes and their genetic clusters circulating at the same 2 5 3 time provides a unique opportunity to monitor virus evolution at both the genotype and 2 5 4 phenotype levels. Past studies on HIV-1 evolution were mainly focused on virus genotype not phenotype, China. In the large cross sectional data from the NHMES, we discovered significant 2 6 0 difference in CD4 count between people infected by CRF01_AE cluster 4 and 5, at both 2 6 1 early and later stage of infection. The lower CD4 count in cluster 4 is directly associated 2 6 2 with the higher prevalence of X4 virus based on genotypic prediction. This genotype- genotyping and phenotyping data from a MSM sero-incidence cohort. We observed that 2 6 5 among sero-convertors, those harboring X4-using viruses had rapid CD4 loss. It is usually considered that X4 variants emerge during late stage of infection, with the with rapid CD4 decline and faster progression to AIDS (16, [25] [26] [27] [28] [29] [30] . The exact time of 2 7 1 coreceptor switch in different HIV-1 subtypes are not well understood. A recent study 2 7 2 did not detect X4 variants in subtype B infected people who were within 2 years of 2 7 3 infection (31). We demonstrated here that in certain HIV-1 subtypes or clusters, such as 2 7 4 CRF01_AE cluster 4, coreceptor switch can occur much earlier than previously thought. This unusually fast speed of coreceptor switch is associated with the rapid CD4 loss in by genetic and structural analysis, the unique V3 signatures in cluster 4 (R13 and K32), high coreceptor switch tendency. Further efforts are required to understand whether the 2 8 0 rapid emergence of X4 virus in vivo is essentially a random event due to accumulation 1 3 envelope positions outside of the V3 loop like V1V2 could also play a part in this 2 8 3 process. A better understanding of the driving force and evolutionary pathway for 2 8 4 coreceptor switch in CRF01_AE cluster 4 may lead to strategies to block the early 2 8 5 emergence of X4 virus during infection. The genetic features of the X4 variants in CRF01_AE cluster 4 are also different from 2 8 8 previously found in other HIV-1 subtypes. In particular, none of the X4 sequences in 2 8 9 CRF01_AE cluster 4 have positively charged amino acid (R or K) at V3 positions 11 or 2 9 0 25, which are key amino acids for X4 usage observed in other subtypes (19-21). Instead, 2 9 1 all of them lost the V3 glycan (the N301 glycan), and nearly all have residue K at V3 2 9 2 position 7. This highlights different evolutionary pathways for coreceptor switching in 2 9 3 different HIV-1 subtypes. N301 glycan has previously been shown to be functionally 2 9 4 critical for both coreceptor utilization and virus replication in subtype B (32, 33). With 2 9 5 compensatory mutations or a high V3 net charge, loss of the N301 glycan leads to 2 9 6 switch from R5 to X4 phenotype (32, 33) . However, in the absence of compensatory 2 9 7 mutations, loss of this glycan can abolish virus replication (32). Possibility due to this 2 9 8 high fitness constraint, N301 glycan is highly conserved in naturally occurring subtype B 2 9 9 sequences. A recent study found that in the Los Alamos HIV database, N301 glycan is 3 0 0 present in as high as 99% of subtype B sequences with R5 phenotype and more than 3 0 1 80% of sequences with X4 phenotype. Differently, in CRF01_AE, 94% of R5 sequences Another interesting finding is the outgrowth of highly replication competent X4 variants 3 0 9
in primary viral isolates from CRF01_AE cluster 4. The low frequency of those X4 3 1 0 variants in plasma may not be explained by their low replication fitness, as they rapidly 3 1 1 outcompete other lineages in the in vitro setting. Instead, it is more likely due to the 3 1 2 compartmentalization of the R5 and X4 viruses in different cell subsets or tissues in vivo. replicate in the memory and naïve CD4 subsets, respectively (37-41). It has been 3 1 6
shown that naïve CD4 T cells produce viruses at a lower propagation rate than memory shut the viruses less efficiently into the blood. Regardless of the mechanism, this 3 2 0 observation has its clinical implication: because conventional sequencing method may 3 2 1 not be sensitive enough to capture those minor X4 variants in plasma, deep sequencing 3 2 2 or phenotypic assay would be required to determine the existence of X4 variants in vivo, 3 2 3 especially when using treatment regimens including the CCR5 inhibitor. In summary, we for the first time demonstrated that various phylogenetic clusters of the and viral pathogenesis, while cluster 5 became more attenuated due to a decreased 3 3 0 potential of using CXCR4. Whether the process of "phenotype divergence" occurred as 3 3 1 a random founder event from the initial seeding clusters, or due to adaptation to 3 3 2 different hosts or transmission routs remains to be studied. Our study emphasizes the The study participants were from the national HIV molecular epidemiology survey In order to distinguish recent HIV-1 infections from long-term HIV-1 infections, the 3 4 7
Enzyme Immunoassay (EIA) was performed using the Maxim HIV-1 Limiting Antigen- RNA was used for cDNA synthesis using the SuperScript III reverse transcriptase The Illumina MiSeq library was prepared using a nested PCR approach. The 8 nt 3 6 0
Illumina index and adaptors (P5 and P7) were added to both ends of the second round PCR primers (SI Appendix, Fig. S2 and Table S4 ). The second round PCR products 3 6 2 were gel-purified to remove unspecific bands and primer dimers, and quantified by The pooled DNA library was sequenced on an Illumina MiSeq using the MiSeq Reagent Kit v2 (500 cycles, Illumina) as previously described (46). Each pair of fastq reads in 3 6 9
files "read 1" and "read 2" were merged by the FLASH software (47). The merged fastq 3 7 0 files were then filtered based on data quality on the Galaxy server (48) using the 3 7 1 following parameter: no more than 10 bases with Q score lower than 30 in each read. The filtered clean reads were then converted into fasta format. In each individual, 3 7 3 identical reads were collapsed into haplotypes after the primer regions were trimmed. The frequency of each haplotype among the total clean reads was calculated. The most Genotypic prediction of co-receptor usage was performed using the Geno2pheno clonal by calculating the frequency of each V3 haplotype among the total reads analyzed. To obtain primary virus isolates, cryopreserved PBMC from HIV-1 infected patients 3 9 0 were co-cultivated with stimulated normal PBMC from healthy donors. In brief, fresh 3 9 1 PBMC from healthy donors were stimulated for 3 days in RPMI1640 containing 10% The p24 concentration in the culture supernatant was measured every week. Majority of 4 0 4 cultures achieved peak p24 production around week 3. Cultures with p24 concentration 4 0 5 less than 2 ng/ml at week 4 were considered to be failed. Coreceptor tropism of the primary viral isolates was determined using the Ghost cell lines and viral p24 production were used to determine the coreceptor usage. Single genome amplification (SGA) was performed as previously described (52) Newly generated nucleic acid sequences in the current study were deposited in 4 2 7
GenBank with accession numbers MH672692-MH673032. Virology 512:222-233. Cluster 4 (n=304)
Cluster 5 (n=271) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S------------------ 
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